Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...

The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. This has been issued for four weeks’ ...

Implantable cardioverter defibrillators (ICDs) are small, battery-powered devices that are implanted under the skin just below the collarbone, with leads (tiny wires) inserted into the heart. The ...

About 7000 implantable cardioverter-defibrillators are implanted annually in Canada to prevent sudden death.1 However, patient preferences may change, and goals of care may shift to improving quality ...

Implantable cardioverter defibrillators are devices implanted in a patient’s chest with the ability to terminate ventricular arrhythmias. Termination of these ventricular arrhythmias is vital to ...

The incidence of sudden cardiac death is high during the early months after an MI. Whether the wearable cardioverter–defibrillator can protect against sudden death during this high-risk period is ...

Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

An extravascular ICD with a substernal lead might retain the benefits, and avoid the risks, of transvenous and subcutaneous ICDs, but data on safety and efficacy are needed. New research findings are ...

St. Louis Blues defenseman Jay Bouwmeester, who needed a defibrillator to be revived after suffering a cardiac episode on the team bench during a game, has undergone a successful Implantable ...